OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Excitotoxicity as a Target Against Neurodegenerative Processes
O Binvignat, Jordi Olloquequi
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1251-1262
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer’s disease
Shan Ping Yu, Michael Qize Jiang, Seong S. Shim, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 56

Therapeutic and Toxic Effects of Valproic Acid Metabolites
N. А. Shnayder, V. V. Grechkina, Aiperi K. Khasanova, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 49

Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 16

Neuroprotective Function of High Glycolytic Activity in Astrocytes: Common Roles in Stroke and Neurodegenerative Diseases
Shinichi Takahashi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6568-6568
Open Access | Times Cited: 74

Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 6, pp. 571-595
Closed Access | Times Cited: 9

Multiple Metabolites Derived from Mushrooms and Their Beneficial Effect on Alzheimer’s Diseases
Zijian Tong, Guodong Chu, Chenmeng Wan, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2758-2758
Open Access | Times Cited: 20

Gypenoside XVII Reduces Synaptic Glutamate Release and Protects against Excitotoxic Injury in Rats
Cheng-Wei Lü, Tzu‐Yu Lin, Kuan‐Ming Chiu, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 589-589
Open Access | Times Cited: 6

Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Alejandro Quintero-Villegas, Sergio Iván Valdés‐Ferrer
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 27

Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
Lijun Ge, Shuyuan Liu, Limor Rubin, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 666-666
Open Access | Times Cited: 26

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
Flora Mikaeloff, Sara Svensson Akusjärvi, George Mondinde Ikomey, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 25

MECP2 and the biology of MECP2 duplication syndrome
Santosh R. D’Mello
Journal of Neurochemistry (2021) Vol. 159, Iss. 1, pp. 29-60
Open Access | Times Cited: 29

Circular RNA in Acute Central Nervous System Injuries: A New Target for Therapeutic Intervention
Li Zhang, Zhenxing Li, Lei Mao, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 21

Astaxanthin Protection against Neuronal Excitotoxicity via Glutamate Receptor Inhibition and Improvement of Mitochondrial Function
Swapna Kannothum Kandy, Madhura Milind Nimonkar, Suravi Sasmita Dash, et al.
Marine Drugs (2022) Vol. 20, Iss. 10, pp. 645-645
Open Access | Times Cited: 19

Pharmacological effects of herbal ingredients of Manasamitra vatakam in the treatment of Alzheimer's disease: A review
Anju C Nair, Beena Briget Kuriakose, A. R. Biju, et al.
Journal of Ayurveda and Integrative Medicine (2025) Vol. 16, Iss. 1, pp. 101041-101041
Open Access

Central Nervous System: Sleep, Cognition and Neuroprotection
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 97-107
Closed Access

Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer’s Disease
Teng Wan, Mingyuan Fu, Yan Jiang, et al.
Neurochemical Research (2021) Vol. 47, Iss. 2, pp. 205-217
Open Access | Times Cited: 25

Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery
Cindy Santiago-Castañeda, Saúl Huerta de la Cruz, Christopher Martínez-Aguirre, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 16

Chronic suppression of STIM1-mediated calcium signaling in Purkinje cells rescues the cerebellar pathology in spinocerebellar ataxia type 2
Polina A. Egorova, Ksenia S. Marinina, Ilya Bezprozvanny
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 5, pp. 119466-119466
Open Access | Times Cited: 9

Inhibitory Role of L-theanine, a Structural Analogue of Glutamate, against GluR5 Kainate Receptor and its Prospective Utility against Excitotoxicity
Satarupa Deb, Anupom Borah
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 3, pp. 317-327
Closed Access | Times Cited: 3

Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets
Soudabeh Naderi, Fariba Khodagholi, Mahyar Janahmadi, et al.
Neuropharmacology (2024) Vol. 263, pp. 110210-110210
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top